BG102837A - Среда за култивиране на клетки от бозайници - Google Patents

Среда за култивиране на клетки от бозайници Download PDF

Info

Publication number
BG102837A
BG102837A BG102837A BG10283798A BG102837A BG 102837 A BG102837 A BG 102837A BG 102837 A BG102837 A BG 102837A BG 10283798 A BG10283798 A BG 10283798A BG 102837 A BG102837 A BG 102837A
Authority
BG
Bulgaria
Prior art keywords
cells
culture medium
hepatocytes
hbm
cell
Prior art date
Application number
BG102837A
Other languages
Bulgarian (bg)
English (en)
Inventor
Geoffrey Block
Original Assignee
University Of Pittsburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Pittsburgh filed Critical University Of Pittsburgh
Publication of BG102837A publication Critical patent/BG102837A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/12—Hepatocyte growth factor [HGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/148—Transforming growth factor alpha [TGF-a]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BG102837A 1996-03-18 1998-10-12 Среда за култивиране на клетки от бозайници BG102837A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/617,325 US6043092A (en) 1996-03-18 1996-03-18 Cell culture media for mammalian cells
PCT/US1997/003880 WO1997034999A1 (en) 1996-03-18 1997-03-12 Cell culture media for mammalian cells

Publications (1)

Publication Number Publication Date
BG102837A true BG102837A (bg) 1999-05-31

Family

ID=24473190

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102837A BG102837A (bg) 1996-03-18 1998-10-12 Среда за култивиране на клетки от бозайници

Country Status (18)

Country Link
US (5) US6043092A (de)
EP (1) EP0929662B1 (de)
KR (1) KR20000064667A (de)
CN (1) CN1217745A (de)
AT (1) ATE343629T1 (de)
AU (1) AU733373B2 (de)
BG (1) BG102837A (de)
BR (1) BR9708105A (de)
CA (1) CA2249289A1 (de)
CZ (1) CZ297198A3 (de)
DE (1) DE69736861D1 (de)
EA (1) EA199800835A1 (de)
IL (1) IL126273A0 (de)
NO (1) NO984314L (de)
NZ (1) NZ331935A (de)
PL (1) PL328922A1 (de)
TR (1) TR199801859T2 (de)
WO (1) WO1997034999A1 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0891419A4 (de) 1996-03-12 2000-03-01 Life Technologies Inc Nährstoffzusatz für hematopoetische zellkulturen
EP2221361A3 (de) 1996-08-30 2011-02-09 Life Technologies Corporation Methode zur Herstellung eines Polypeptids in vitro in einer Säugerzelle in einem Kulturmedium ohne Serum und ohne Proteine
US6692961B1 (en) 1996-10-11 2004-02-17 Invitrogen Corporation Defined systems for epithelial cell culture and use thereof
WO2000018885A1 (en) 1998-09-29 2000-04-06 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
EP0953633A1 (de) * 1998-04-28 1999-11-03 Livercell L.L.C. Zellkulturverfahren und Medium zur Herstellung von vermehrungsfähige, normale, differenzierte Humane Leberzellen
JP3553858B2 (ja) * 1999-08-25 2004-08-11 東洋紡績株式会社 血管網類似構造体を有する細胞培養用モジュール
US6767741B1 (en) 1999-08-27 2004-07-27 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
EP1210410B1 (de) * 1999-08-27 2008-01-16 Invitrogen Corporation Metallbindende verbindungen und deren verwendung in zusammensetzungen für zellkulturmedien
IL136232A0 (en) * 2000-05-18 2001-05-20 Bar Ilan University Res Author Measurements of enzymatic activity in a single, individual cell in population
AU2001260658A1 (en) * 2000-06-01 2001-12-11 Hokkaido Technology Licensing Office Co., Ltd. Method of preparing small hepatocytes preservable in freeze-dried state and method of preserving the same in freeze-dried state
US6762053B2 (en) * 2000-06-09 2004-07-13 Vitrolife, Inc. Mammalian gamete and embryo culture media and culture media supplements
EP1356286A2 (de) * 2000-11-17 2003-10-29 Takeda Pharmaceutical Company Limited Methode zur bestimmung der stoffwechselfunktion eines xenobiotikum sowie ihrer induktion
US6506576B2 (en) 2001-03-14 2003-01-14 Board Of Trustees Of The University Of Arkansas Serum-and steroid-free culture media for cerebellar granule neurons
JP4344231B2 (ja) * 2001-05-16 2009-10-14 財団法人神奈川科学技術アカデミー ｄｌｋを用いた未分化肝細胞の検出及び分離方法
EP1321515A1 (de) * 2001-12-21 2003-06-25 Ingenium Pharmaceuticals AG Zellkulturverfahren
IL152904A0 (en) * 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
WO2003062404A1 (en) 2002-01-25 2003-07-31 Gamida-Cell Ltd. Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
AU2003214614B2 (en) * 2002-03-18 2008-11-20 Gamida-Cell Ltd. Methods of inducing differentiation in ex vivo expanded stem cells
TWI288779B (en) * 2002-03-28 2007-10-21 Blasticon Biotech Forschung Dedifferentiated, programmable stem cells of monocytic origin, and their production and use
EP1499710B1 (de) * 2002-03-29 2011-08-24 Singapore Eye Research Institute Verfahren zum wachstum von menschlichen bindehautgewebeäquivalenten für die forschung, die klinische augenoberflächentransplantation und die geweberekonstruktion
CA2481953A1 (en) * 2002-04-04 2003-10-16 Daiichi Pure Chemicals Co., Ltd. Method of culturing liver cells over long time
CA2487094A1 (en) * 2002-05-28 2003-12-11 Becton, Dickinson And Company Methods for in vitro expansion and transdifferentiation of human pancreatic acinar cells into insulin-producing cells
US20050054097A1 (en) * 2002-11-17 2005-03-10 Tony Peled EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
US7332303B2 (en) * 2002-12-23 2008-02-19 Bristol-Myers Squibb Company Product quality enhancement in mammalian cell culture processes for protein production
IL154677A0 (en) 2003-02-27 2003-09-17 Univ Bar Ilan A method and apparatus for manipulating an individual cell
AU2004217699B2 (en) * 2003-03-07 2008-07-03 Gamida-Cell Ltd. Expansion of renewable stem cell populations using modulators of PI 3-kinase
US20040229355A1 (en) * 2003-05-14 2004-11-18 Board Of Regents University Of Texas System Culture medium for long-term culture of hepatocytes
WO2004103333A1 (de) * 2003-05-24 2004-12-02 Juvena (International) Ag Gewebekulturmedien als bestandteil von kosmetika
US9200245B2 (en) 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
US8597597B2 (en) 2003-06-26 2013-12-03 Seng Enterprises Ltd. Picoliter well holding device and method of making the same
US7888110B2 (en) 2003-06-26 2011-02-15 Seng Enterprises Ltd. Pico liter well holding device and method of making the same
WO2005005608A2 (en) * 2003-06-30 2005-01-20 Lifescan, Inc. Compositions and methods for differentiating adipose stromal cells into pancratic beta cells
WO2005008626A1 (en) * 2003-07-11 2005-01-27 University Of North Carolina At Chapel Hill Methods and systems for controlling a computer using a video image and for combining the video image with a computer desktop
US20050064524A1 (en) * 2003-08-11 2005-03-24 Mordechai Deutsch Population of cells utilizable for substance detection and methods and devices using same
ATE466073T1 (de) * 2003-12-26 2010-05-15 Makoto Asashima Basalmedium zur kultivierung von es-zellen
EP1711166A1 (de) * 2004-02-03 2006-10-18 Chemagis Ltd. Stabile amorphe formen von montelukast natrium
EP1609462B1 (de) * 2004-04-22 2015-07-29 La Prairie Group AG Kosmetische oder dermatologische Zubereitung umfassend eine Nährmedienphase
KR20060000547A (ko) * 2004-06-29 2006-01-06 라이프코드인터내셔날 주식회사 대량의 간세포 배양 및 간세포 구상체 형성용 고농도 배지
US7403647B2 (en) * 2004-09-13 2008-07-22 Seng Enterprises Ltd. Method for identifying an image of a well in an image of a well-bearing component
EP1799812A4 (de) 2004-09-16 2009-09-09 Gamida Cell Ltd Verfahren zur ex-vivo-expansion von progenitor- und stammzellen durch gemeinsame kultivierung mit mesenchymzellen
EP1866075B1 (de) 2005-01-25 2010-09-08 Seng Enterprises Limited Mikrofluidische vorrichtung zur untersuchung zellen
US7409239B2 (en) * 2005-05-05 2008-08-05 The Hong Kong Polytechnic University Method for predicting the blood glucose level of a person
DE102005031532A1 (de) * 2005-07-01 2007-01-04 Cytonet Gmbh & Co. Kg Lagermedium für Zellen
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
US7989205B2 (en) * 2005-10-06 2011-08-02 American Cryostem Corporation Cell culture media, kits and methods of use
US8288120B2 (en) 2005-11-03 2012-10-16 Seng Enterprises Ltd. Method for studying floating, living cells
US8846393B2 (en) * 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
US20070231901A1 (en) * 2005-12-02 2007-10-04 Shuichi Takayama Microfluidic cell culture media
WO2007087570A2 (en) * 2006-01-24 2007-08-02 Northfield Laboratories, Inc. Polymerized hemoglobin media and its use in isolation and transplantation of islet cells
US20090004159A1 (en) * 2006-01-24 2009-01-01 The Board Of Trustees Of The University Of Illinoi Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
US20060223999A1 (en) * 2006-05-10 2006-10-05 Chemagis Ltd. Process for preparing montelukast and precursors thereof
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
US9975118B2 (en) 2007-11-15 2018-05-22 Seng Enterprises Ltd. Device for the study of living cells
WO2009070722A1 (en) * 2007-11-28 2009-06-04 University Of Massachusetts Lowell CELL CULTURE HYDROGEL WITH pH INDICATOR
EP3061808B1 (de) 2009-02-03 2020-08-12 Koninklijke Nederlandse Akademie van Wetenschappen Nährmedium für epithelstammzellen und organelle mit den besagten stammzellen
EP2412800A1 (de) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Leberorganoid, Verwendungen davon und Kultivierungsverfahren zum Erhalten davon
PL2340033T3 (pl) * 2009-06-26 2014-03-31 Novo Nordisk As Preparat zawierający insulinę, nikotynamid i argininę
EP2467149B1 (de) * 2009-08-17 2018-04-04 Ashok K. Singh Flüssigkeit aus haut und omentum zur medizinischen verwendung
CN102344904B (zh) * 2010-08-02 2014-04-30 深圳华大基因科技有限公司 一种猪细胞培养基
WO2012092542A2 (en) 2010-12-30 2012-07-05 University Of Massachusetts Lowell Responsive cell culture hydrogel
CN102399742B (zh) * 2011-09-30 2014-07-30 东莞中山大学研究院 用于哺乳动物唾液腺上皮细胞和唾液腺干细胞培养的无血清培养液
BR112014020119A2 (pt) 2012-02-13 2020-10-27 Gamida-Cell Ltd cultura de células-tronco mesenquimais
US9493744B2 (en) 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
WO2014082685A1 (en) * 2012-11-30 2014-06-05 Swiss Stem Cell Foundation Serum-free medium for human mesenchymal stem cells
AR095196A1 (es) 2013-03-15 2015-09-30 Regeneron Pharma Medio de cultivo celular libre de suero
PT2977056T (pt) * 2014-07-11 2018-11-07 Grifols Worldwide Operations Ltd Transferrina para usar no tratamento de distúrbios neurodegenerativos relacionados com o factor induzido por hipoxia (fih)
CN106318998B (zh) * 2015-07-08 2019-08-20 浙江海正博锐生物制药有限公司 用于提高重组人ⅱ型肿瘤坏死因子受体-抗体融合蛋白唾液酸化水平的组合物
TW202340452A (zh) 2015-08-04 2023-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法
EP3806650A4 (de) * 2018-06-18 2022-05-11 Oakbio Inc. Verfahren zur herstellung von reichen zellkulturmedien unter verwendung von chemoautotrophen mikroben
US20220290097A1 (en) * 2019-08-03 2022-09-15 Shenzhen Mytang Biotechnology Co., Ltd. Poultry Egg-Based Culture Medium
CN115369087B (zh) * 2021-05-17 2024-02-09 合肥中科普瑞昇生物医药科技有限公司 肝癌原代细胞的培养基及培养方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4439521A (en) * 1981-10-21 1984-03-27 Ontario Cancer Institute Method for producing self-reproducing mammalian pancreatic islet-like structures
FR2543158B1 (fr) * 1983-03-24 1985-11-15 Inst Nat Sante Rech Med Milieu de culture de cellules animales sans serum, sans hormones et sans facteurs de croissance et procedes de culture primaire et d'obtention de lignees cellulaires utilisant ce milieu
US4902295A (en) * 1985-08-26 1990-02-20 Hana Biologics, Inc. Transplantable artificial tissue
NO162160C (no) * 1987-01-09 1989-11-15 Medi Cult As Serumfritt vekstmedium, samt anvendelse derav.
DE3711699A1 (de) * 1987-04-07 1988-11-10 Fraunhofer Ges Forschung Medium zur kultivierung und proliferation von epithelialen zelltypen
EP0449950A4 (en) * 1988-12-14 1991-10-16 Us Health Cell culture medium for human liver epithelial cell line
US5529920A (en) * 1988-12-14 1996-06-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Human liver epithelial cell line and culture media therefor
US5380660A (en) * 1989-02-02 1995-01-10 New England Medical Center Hospitals, Inc. Method of treating serum or serum-containing medium to inactivate an inhibitor of hepatocyte differentiation
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
JPH0728732B2 (ja) * 1990-04-17 1995-04-05 日本石油株式会社 動物細胞増殖促進剤及び無血清培地
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
DK0605428T5 (da) * 1991-06-24 2003-01-06 Hcell Technology Inc Hormonsecernerende pancreasceller opretholdt i langtidskultur
US5116753A (en) * 1991-07-30 1992-05-26 The Salk Institute For Biological Studies Maintenance of pancreatic islets
CA2115140A1 (en) * 1991-08-07 1993-02-18 Lola M. Reid Proliferation of hepatocyte precursors
ES2157225T3 (es) * 1992-10-09 2001-08-16 Advanced Tissue Sciences Inc Celulas hepaticas de reserva.
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
US5587309A (en) * 1994-04-29 1996-12-24 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating proliferation and differentiation of human fetal pancreatic cells ex vivo
US5695998A (en) * 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells

Also Published As

Publication number Publication date
AU733373B2 (en) 2001-05-10
BR9708105A (pt) 2000-01-04
ATE343629T1 (de) 2006-11-15
CN1217745A (zh) 1999-05-26
US7022520B2 (en) 2006-04-04
EP0929662A1 (de) 1999-07-21
EP0929662A4 (de) 2002-12-04
CA2249289A1 (en) 1997-09-25
TR199801859T2 (xx) 1999-02-22
CZ297198A3 (cs) 1999-03-17
NO984314L (no) 1998-11-17
EP0929662B1 (de) 2006-10-25
US20040166579A1 (en) 2004-08-26
EA199800835A1 (ru) 1999-02-25
NZ331935A (en) 2000-05-26
DE69736861D1 (de) 2006-12-07
US6670180B2 (en) 2003-12-30
AU2528797A (en) 1997-10-10
NO984314D0 (no) 1998-09-17
IL126273A0 (en) 1999-05-09
WO1997034999A1 (en) 1997-09-25
KR20000064667A (ko) 2000-11-06
PL328922A1 (en) 1999-03-01
US6043092A (en) 2000-03-28
US6413772B1 (en) 2002-07-02
US20060141447A1 (en) 2006-06-29
US20020155603A1 (en) 2002-10-24

Similar Documents

Publication Publication Date Title
BG102837A (bg) Среда за култивиране на клетки от бозайници
US5712159A (en) Glucose responsive insulin secreting β-cell lines and method for producing same
US6692961B1 (en) Defined systems for epithelial cell culture and use thereof
Ambesi-Impiombato et al. Thyroid cells in culture
US7217570B2 (en) Organotypic intestinal culture and methods of use thereof
Brandi et al. Bovine parathyroid cells: cultures maintained for more than 140 population doublings.
Romijn Development and advantages of serum‐free, chemically defined nutrient media for culturing of nerve tissue
WO2005085422A9 (en) Adult stem cells and uses thereof
JP2009106301A (ja) ヒトｃｎｓ神経幹細胞の培養
JP2004121258A (ja) 神経芽細胞の産生方法
BR112012009848B1 (pt) Método de obtenção de células-tronco/progenitoras multipotentes de mamíferos capazes de se diferenciar em linhagens hepáticas e pancreáticas
Kost et al. Effect of 2% dimethyl sulfoxide on the mitogenic properties of epidermal growth factor and hepatocyte growth factor in primary hepatocyte culture
CA2537462A1 (en) Cell culture media comprising fructose as the primary energy source
Takigawa et al. Establishment from a human chondrosarcoma of a new immortal cell line with high tumorigenicity in vivo, which is able to form proteoglycan‐rich cartilage‐like nodules and to respond to insulin in vitro
JP2016515403A (ja) ニューロン細胞培養のための培地組成物
Rizzino et al. The effects of laminin on the growth and differentiation of embryonal carcinoma cells in defined media
RU2333243C2 (ru) Дедифференцированные программируемые стволовые клетки моноцитарного происхождения и их получение и применение
WO1997016536A1 (en) Method for ex vivo proliferation and differentiation of adult pancreatic islet cells, media useful therefor and uses thereof
Toda et al. Plural cells organize thyroid follicles through aggregation and linkage in collagen gel culture of porcine follicle cells
JP2003530103A5 (de)
JP2000512128A (ja) 哺乳類細胞用の細胞培養培地
MXPA98007554A (en) Cellular cultivation media for mamif cells
EP1059352A1 (de) Langzeitkultur humaner Karzinome
WO2005045012A1 (en) Endodermal stem cells in liver and methods for isolation thereof
CA3070750A1 (en) Functional feline pancreatic cells from adipose tissue